Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors

被引:19
作者
Chu, GH
Milano, S
Kluth, L
Rhodes, M
Boni, R
Johnson, DA
Li, PK
机构
[1] DUQUESNE UNIV,SCH PHARM,GRAD SCH PHARMACEUT SCI,DIV MED CHEM,PITTSBURGH,PA 15282
[2] DUQUESNE UNIV,SCH NAT & ENVIRONM SCI,DEPT CHEM,PITTSBURGH,PA 15219
关键词
estrone sulfatase; mammary carcinoma; sulfatase inhibitors; hormone dependence;
D O I
10.1016/S0039-128X(97)00038-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, we reported the synthesis and biochemical studies of a series of (p-O-sulfamoyl)-N-alkanoyl tyramines as nonsteroidal estrone sulfatase inhibitors. One of the most potent inhibitors in this series is (p-O-sulfamoyl)-N-tridecanoyl tyramine 1 with an IC50 value of 61.3 nM. In this study, we synthesized four analogs of 1 (compounds 2-5) to investigate the structure-activity relationships of the amide functionality in (p-O-sulfamoyl)-N-tridecanoyl tyramine. Replacement of the amide functionality in 1 with an ethylene moiety to form the alkyl analog 5 resulted in complete loss of sulfatase inhibitory activity (IC50 of 61.3 nM vs. >20 mu M). The keto, hydroxy, and ester analogs (inhibitors 2-4) are 8-15 times less in affinity to the sulfatase than inhibitor 1. However, their inhibitory activities are significantly higher than the alkyl analog 5. The results suggest that the amide functionality is favorable for sulfatase inhibitory activity and that there may be a hydrogen bonding component to the enzyme interaction in this region. (C) 1997 by Elsevier Science Inc.
引用
收藏
页码:530 / 535
页数:6
相关论文
共 9 条
[1]  
ELGER W, 1995, J STEROID BIOCHEM, V55, P396
[2]   Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors [J].
Li, PK ;
Milano, S ;
Kluth, L ;
Rhodes, ME .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 59 (01) :41-48
[3]   ESTRONE SULFATE-SULFATASE AND 17-BETA-HYDROXYSTEROID DEHYDROGENASE-ACTIVITIES - A HYPOTHESIS FOR THEIR ROLE IN THE EVOLUTION OF HUMAN BREAST-CANCER FROM HORMONE-DEPENDENCE TO HORMONE-INDEPENDENCE [J].
PASQUALINI, JR ;
CHETRITE, G ;
NGUYEN, BL ;
MALOCHE, C ;
DELALONDE, L ;
TALBI, M ;
FEINSTEIN, MC ;
BLACKER, C ;
BOTELLA, J ;
PARIS, J .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 53 (1-6) :407-412
[4]  
POWARTH NM, 1994, J MED CHEM, V37, P219
[5]   INACTIVATION OF STEROID SULFATASE BY AN ACTIVE-SITE-DIRECTED INHIBITOR, ESTRONE-3-O-SULFAMATE [J].
PUROHIT, A ;
WILLIAMS, GJ ;
HOWARTH, NM ;
POTTER, BVL ;
REED, MJ .
BIOCHEMISTRY, 1995, 34 (36) :11508-11514
[6]  
PUROHIT A, 1995, INT J CANCER, V63, P109
[7]   PLASMA ESTRONE-SULFATE ASSESSMENT OF REDUCED ESTROGEN PRODUCTION DURING TREATMENT OF METASTATIC BREAST-CARCINOMA [J].
SAMOJLIK, E ;
SANTEN, RJ ;
WORGUL, TJ .
STEROIDS, 1982, 39 (05) :497-507
[8]   ENZYMATIC CONTROL OF ESTROGEN PRODUCTION IN HUMAN-BREAST CANCER - RELATIVE SIGNIFICANCE OF AROMATASE VERSUS SULFATASE PATHWAYS [J].
SANTEN, RJ ;
LESZCZYNSKI, D ;
TILSONMALLET, N ;
FEIL, PD ;
WRIGHT, C ;
MANNI, A ;
SANTNER, SJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 464 :126-137
[9]   INSITU ESTROGEN PRODUCTION VIA THE ESTRONE SULFATASE PATHWAY IN BREAST-TUMORS - RELATIVE IMPORTANCE VERSUS THE AROMATASE PATHWAY [J].
SANTNER, SJ ;
FEIL, PD ;
SANTEN, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (01) :29-33